| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.44B | 29.33B | 27.43B | 23.79B | 21.91B | 21.08B |
| Gross Profit | 9.39B | 9.37B | 8.39B | 7.96B | 7.30B | 6.68B |
| EBITDA | 3.80B | 3.80B | 3.00B | 2.80B | 2.29B | 2.01B |
| Net Income | 1.90B | 1.99B | 1.76B | 1.54B | 1.05B | 1.29B |
Balance Sheet | ||||||
| Total Assets | 36.67B | 37.77B | 36.53B | 36.29B | 31.55B | 30.40B |
| Cash, Cash Equivalents and Short-Term Investments | 8.28B | 8.13B | 7.30B | 9.18B | 7.33B | 6.99B |
| Total Debt | 2.48B | 2.61B | 3.04B | 3.40B | 2.26B | 2.59B |
| Total Liabilities | 12.12B | 12.73B | 13.34B | 14.71B | 11.39B | 10.90B |
| Stockholders Equity | 21.62B | 21.98B | 20.26B | 18.78B | 17.56B | 16.64B |
Cash Flow | ||||||
| Free Cash Flow | 316.00M | 1.84B | -1.25B | 1.20B | 1.11B | 1.59B |
| Operating Cash Flow | 522.50M | 2.54B | 101.00M | 1.62B | 1.88B | 2.34B |
| Investing Cash Flow | -189.50M | -667.00M | 81.00M | -564.00M | -578.00M | -748.72M |
| Financing Cash Flow | -336.50M | -1.10B | -1.10B | 655.00M | -978.00M | -968.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥153.25B | 14.32 | ― | 3.23% | 5.32% | -3.12% | |
80 Outperform | ¥28.12B | 13.32 | ― | 2.89% | 11.21% | 19.46% | |
80 Outperform | ¥78.82B | 8.26 | ― | 2.31% | 3.01% | 4.40% | |
75 Outperform | ¥74.38B | 12.98 | ― | 3.12% | 2.81% | -4.38% | |
72 Outperform | ¥22.68B | 7.24 | ― | 2.84% | 4.18% | 2.42% | |
66 Neutral | ¥9.11B | 7.40 | ― | 2.45% | 14.74% | -73.19% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |